Boston Scientific Corp. (BSX)

33.52
0.22 0.66
NYSE : Health Technology
Prev Close 33.30
Open 33.35
Day Low/High 33.30 / 33.56
52 Wk Low/High 24.54 / 37.30
Volume 2.70M
Avg Volume 7.25M
Exchange NYSE
Shares Outstanding 1.38B
Market Cap 46.40B
EPS 0.10
P/E Ratio 88.29
Div & Yield N.A. (N.A)

Latest News

Boston Scientific Announces Agreement To Acquire VENITI, Inc.

Boston Scientific Announces Agreement To Acquire VENITI, Inc.

Acquisition to Bolster Company's Venous Therapies Portfolio within Peripheral Interventions Division

Boston Scientific Closes Acquisition Of Claret Medical, Inc., Announces Positive Reimbursement Decision

Boston Scientific Closes Acquisition Of Claret Medical, Inc., Announces Positive Reimbursement Decision

CMS Grants NTAP Designation for The Sentinel® Cerebral Protection System

Boston Scientific To Participate In 38th Annual Canaccord Genuity Growth Conference

Boston Scientific To Participate In 38th Annual Canaccord Genuity Growth Conference

MARLBOROUGH, Mass., July 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 38 th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston.

Boston Scientific Announces Results For Second Quarter 2018

Boston Scientific Announces Results For Second Quarter 2018

MARLBOROUGH, Mass., July 25, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.

Boston Scientific Corporation Recommends Stockholders Reject 'Mini-Tender' Offer By TRC Capital Corporation

Boston Scientific Corporation Recommends Stockholders Reject 'Mini-Tender' Offer By TRC Capital Corporation

MARLBOROUGH, Mass., July 24, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation (TRC) to purchase up to three million shares of Boston Scientific's common...

Boston Scientific Announces Agreement To Acquire Claret Medical, Inc.

Boston Scientific Announces Agreement To Acquire Claret Medical, Inc.

Addition of FDA-cleared Sentinel® Cerebral Embolic Protection System to Expand Company's Structural Heart Offerings

Boston Scientific To Acquire Cryterion Medical, Inc.

Boston Scientific To Acquire Cryterion Medical, Inc.

Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform

Boston Scientific Announces Conference Call Discussing Second Quarter 2018 Financial Results

Boston Scientific Announces Conference Call Discussing Second Quarter 2018 Financial Results

MARLBOROUGH, Mass., July 2, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2018 on Wednesday, July 25, 2018 at 8:00...

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.

Magellan Midstream, Xylem, Boston Scientific: 'Mad Money' Lightning Round

Magellan Midstream, Xylem, Boston Scientific: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.

How to Handle the Fed: Cramer's 'Mad Money' Recap (Wednesday 6/13/18)

How to Handle the Fed: Cramer's 'Mad Money' Recap (Wednesday 6/13/18)

Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss the AT&T/Time Warner ruling, Alzheimer plays, and day traders risk.

Stryker Says Not in Talks to Buy Boston Scientific

Stryker Says Not in Talks to Buy Boston Scientific

The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks closed higher on Monday as Wall Street prepares for an extraordinary week for risk events around the world.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The major U.S. averages closed the day in the green Monday.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss Trump and stocks, trade, and pajama trading.

Boston Scientific Jumps on Report of Stryker Takeover Approach

Boston Scientific Jumps on Report of Stryker Takeover Approach

The Wall Street Journal reports Stryker made a takeover approach for the medical device company.

Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018

Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018

MARLBOROUGH, Mass., June 1, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced key data that will be presented at Digestive Disease Week (DDW) being held in Washington D.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others

Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others

The insurgent manager who helped engineer the Amazon-Whole Foods combination opened a window into his latest allocations, any of which could become campaigns. Here's a wrap up of his investments as well as new developments from Mick McGuire's Marcato Capital and Dan Loeb's Third Point.

Boston Scientific Announces Real-World Data Demonstrating Success Of SMART Pass On The S-ICD System

Late-Breaker Data Highlight Reduction in Rate of Inappropriate Shocks with Sensing Filter

Boston Scientific Announces Acquisition Of Securus Medical Group, Inc.

Boston Scientific Announces Acquisition Of Securus Medical Group, Inc.

Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor

Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation

Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation

U.K. Court Affirms that Edwards Lifesciences Infringes Boston Scientific Patent

TheStreet Quant Rating: A- (Buy)